Your browser doesn't support javascript.
loading
Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.
Li, Fei; Xu, Yan; Deng, Ping; Yang, Ye; Sui, Weiwei; Jin, Fengyan; Hao, Mu; Li, Zengjun; Zang, Meirong; Zhou, Dehui; Gu, Zhimin; Ru, Kun; Wang, Jianxiang; Cheng, Tao; Qiu, Lugui.
Afiliação
  • Li F; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Xu Y; Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Deng P; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Yang Y; Department of Science and Education, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Sui W; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52246, USA.
  • Jin F; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Hao M; Tumor Center, The First Hospital of Jilin University, Changchun 130021, China.
  • Li Z; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Zang M; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Zhou D; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Gu Z; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Ru K; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52246, USA.
  • Wang J; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Cheng T; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
  • Qiu L; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
Oncotarget ; 6(11): 9434-44, 2015 Apr 20.
Article em En | MEDLINE | ID: mdl-25831238
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 12 / Deleção Cromossômica / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteassoma / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 12 / Deleção Cromossômica / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteassoma / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article